kintara have anoounced that their drug have not performed better than standard care of treatment...with this both bayer and kintara have ended their journey of glibostoma...we already know that paxalisb have not graduated to stage 2...so we dont really have much hope from paxalisb either..but we have not got negative result as of this posting even though we have started journey as same time as kintara which give us liitle bit of hope.. albeit lets keep an eye dipg and hope we can recoup our losses
KZA Price at posting:
7.0¢ Sentiment: Hold Disclosure: Held
